Skip to main content

Table 2 Participant self-report of reproductive health screening and counseling by healthcare providers

From: Experiences of sexual and reproductive health screening and counseling in the clinical setting among adolescents and young adults with rheumatic disease

     

Current Teratogen Use

   

Overall (N = 108)

 

Teratogen (n = 39)

None (n = 69)

Reproductive Health Screening/Counseling (Has provider ever…)

n (Percent)

 

n (Percent)

n (Percent)

 

Pediatric Rheumatologist:

    
  

Asked about sexual activity

41 (38)

 

21 (54)

20 (29)

  

Counseled risk of disease or medication on health of fetus

35 (32)

 

20 (51)

15 (22)**

  

Told should not get pregnant due to medication for rheumatic disease

29 (27)

 

17 (44)

12 (17)**

  

Talked about how to prevent pregnancy

18 (17)

 

9 (23)

9 (13)

  

Talked about how to get or use emergency contraception

6 (6)

 

3 (8)

3 (4)

  

Received no screening/counseling

50 (46)

 

11 (28)

39 (57)**

 

Any Provider:

    
  

Asked about sexual activity

89 (82)

 

33 (85)

56 (81)

  

Counseled risk of disease or medication on health of fetus

38 (35)

 

21 (54)

17 (25)**

  

Told should not get pregnant due to medication for rheumatic disease

30 (28)

 

17 (44)

13 (19)**

  

Talked about how to prevent pregnancy

60 (56)

 

23 (59)

37 (54)

  

Talked about how to get or use emergency contraception

22 (20)

 

11 (28)

11 (16)

  

Received no screening/counseling

12 (11)

 

5 (13)

7 (10)

Key Knowledge Assessment

    
 

“The medicine I am on for my rheumatic disease could be bad for my baby if I were to become pregnant.”

    
  

Yes

46 (43)

 

24 (62)

22 (32)**

  

No

9 (8)

 

3 (8)

6 (9)

  

Unsure

53 (49)

 

12 (31)

41 (59)

 

“If I get pregnant, I should immediately stop all my medications.”

    
  

Yes

22(20)

 

9 (23)

13 (19)

  

No

18 (17)

 

6 (15)

12 (17)

  

Unsure

68 (63)

 

24 (62)

44 (64)

  1. *p < 0.05
  2. **p < 0.01